OnKure Therapeutics (OKUR) Current Leases (2022 - 2026)

OnKure Therapeutics (OKUR) has reported Current Leases for 5 consecutive years, with $336000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases fell 39.57% year-over-year to $336000.0; the trailing twelve-month figure through Jun 2026 stood at $336000.0 (down 39.57% YoY), and the FY2025 full-year result was $549000.0, up 2.43% from the prior year.
• Current Leases eased to $336000.0 in Q2 2026 per OKUR's latest filing, from $409000.0 in the prior quarter.
• Across five years, Current Leases topped out at $567000.0 in Q3 2025 and bottomed at $208000.0 in Q4 2023.
• Historically, Current Leases has averaged $407777.8 across 5 years, with a median of $406000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Leases slumped 48.51% in 2023, then jumped 157.69% in 2024.
• Over 5 years, Current Leases stood at $404000.0 in 2022, then plunged by 48.51% to $208000.0 in 2023, then surged by 157.69% to $536000.0 in 2024, then climbed by 2.43% to $549000.0 in 2025, then tumbled by 38.8% to $336000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $336000.0, $409000.0, and $549000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.